Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma

Faye M. Johnson, Lee M. Krug, Hai T. Tran, Stephanie Shoaf, Victor G. Prieto, Pheroze Tamboli, Beverly Peeples, Jyoti Patel, Bonnie S. Glisson*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences